Healthcare Costs Will Be $4.8 Trillion In 2021. Will Prochymal for AMI Reduce Heart Failure And Save Money?
"Medicare spending alone will top $1 trillion in 2021, while total U.S. healthcare spending will balloon to $4.8 trillion." -Yahoo News
"Heart failure (HF) ranks among the most costly chronic diseases in developed countries. At present these countries devote 1-2% of all healthcare expenditures towards HF. In the US, these costs are estimated at $US30.2 billion for 2007." -Duke University
"Prochymal Significantly Reduces Hypertrophy, Arrhythmia and Progression to Heart Failure in Patients Suffering a Heart Attack" -Osiris Therapeutics
When will the next round of Phase 2 Prochymal for AMI data be out, Oz? Daniel? Anyone? If Prochymal for AMI works, it will contribute to National debt reduction. The FDA will act accordingly.
Osiris is accepting applications for product collaborations. The following partnerships are available: (1) one for foreign Prochymal/GvHD, (2) one for foreign Grafix, (3) one for local and foreign Ovation, (4) one for local and foreign Cartiform, (5) one for local and foreign Prochymal/AMI and (6) One for local and foreign Prochymal/Crohns.
Upfront cash is needed to particpate plus 20% royalties on all future Sales. The list of possible candidates are shown below and are ordered in size by current revenue, highest to smallest. Pick 6 potential partners from the list below, but one large blockbuster deal will be considered as well as smaller companies in niche markets!
Pfizer (with Wyeth)
Johnson & Johnson
Merck & Co.
Eli Lilly and Company
Takeda Pharmaceutical Co.
Teva Pharmaceutical Industries
Procter & Gamble
Chugai Pharmaceutical Co.
Bausch & Lomb
Taiho Pharmaceutical Co.
Dainippon Sumitomo Pharma
Wouldn't that embarrass Sanofi by highlighting to them that they just committed the biggest blunder of the century? Letting a little company like Osiris outwit the 6th largest Pharma in the world; that speaks volumes about about our little upstart Osiris. Well played Mr. Friedli and Dr. Mills.
When billion dollar Pharmas become arrogant they lose! Sanofi's mistake will go down in the annuals of Pharma history as the biggest faux pas of the century.